KCC-07
CAS No. 315702-75-1
KCC-07( —— )
Catalog No. M22191 CAS No. 315702-75-1
KCC-07 is a selective, potent and brain-penetrant inhibitor of methyl-CpG-binding domain protein 2(MBD2) with anticancer activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 43 | Get Quote |
|
| 5MG | 65 | Get Quote |
|
| 10MG | 113 | Get Quote |
|
| 25MG | 222 | Get Quote |
|
| 50MG | 354 | Get Quote |
|
| 100MG | 527 | Get Quote |
|
| 500MG | 1143 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameKCC-07
-
NoteResearch use only, not for human use.
-
Brief DescriptionKCC-07 is a selective, potent and brain-penetrant inhibitor of methyl-CpG-binding domain protein 2(MBD2) with anticancer activity.
-
DescriptionKCC-07 is a selective, potent and brain-penetrant inhibitor of methyl-CpG-binding domain protein 2(MBD2) with anticancer activity. KCC-07 prevents binding of MBD2 to methylated DNA and activates brain specific angiogenesis inhibitor 1 (BAI1) inducing anti-proliferative BAI1/p53/p21 signaling. In vitro, KCC-07 treatment Medulloblastomas (MB) cells clearly inhibited MB cell growth, consistent with induction of anti-proliferative BAI1/p53/p21 signaling.
-
In VitroCell Viability Assay Cell Line:Medulloblastomas (MB) cells Concentration:10 μM Incubation Time:72 hours Result:Clearly inhibited MB cell growth in vitro.Western Blot Analysis Cell Line:Medulloblastomas (MB) cells Concentration:10 μM Incubation Time:48 hours Result:Largely abrogated MBD2 binding to the ADGRB1 promoter in BAI1-silent MB cells.
-
In VivoAnimal Model:Outbred athymic nude mice (females; 8-10 weeks old) injected with MB cells Dosage:100 mg/kg Administration:Intraperitoneal injection; 5 days/week Result:Significantly extended the survival of MB xenografts in vivo.
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetDNA Alkylator
-
RecptorMBD2 (methyl-CpG-binding domain protein 2)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number315702-75-1
-
Formula Weight269.32
-
Molecular FormulaC14H11N3OS?
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (464.13 mM)
-
SMILESOc1cccc(Nc2nc(cs2)-c2ccccn2)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Dan Zhu, et al. BAI1 Suppresses Medulloblastoma Formation by Protecting p53 From Mdm2-Mediated Degradation. Cancer Cell. 2018 Jun 11;33(6):1004-1016.e5.
molnova catalog
related products
-
Evofosfamide
A potent and selective hypoxia-activated phosphoramidate DNA cross-linking mustard; selectively potent under hypoxia and stable to liver microsomes.
-
Cyclophosphamide hyd...
A synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities; used to treat cancers and autoimmune diseases.
-
OBI-3424
OBI-3424 (AST-3424, TH-3424) is a first-in-class, novel prodrug that selectively targets cancers overexpressing the enzyme AKR1C3, OBI-3424 is a highly selective prodrug that is converted by AKR1C3 to a DNA alkylating agent.
Cart
sales@molnova.com